Last reviewed · How we verify
NCT04147559
Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem
trial testing Total Hip Arthroplasty Implant in Joint Diseases in 150 participants. Enrolling by invitation.
1 May 2033
Quick facts
| Lead sponsor | MicroPort Orthopedics Inc. |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 21 October 2020 |
| Primary completion | 1 May 2033 |
| Estimated completion | 1 November 2033 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Total Hip Arthroplasty Implant
Conditions studied
- Joint Diseases — all drugs for Joint Diseases →
Sponsor
MicroPort Orthopedics Inc.
Who can join
21 and older, any sex, with Joint Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sponsor is conducting this post market clinical study to evaluate the safety and effectiveness of its PROFEMUR® Preserve Classic Femoral Stem. This type of study is required by regulatory authorities for all devices that have been approved in Europe (EU) to evaluate the medium and long-term clinical evidence. This study has been designed in accordance with MEDDEV2.12/2 (European Medical Device Vigilance System) rev2 and ISO (International Organization of Standardization) 14155:2011 guidelines.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04147559
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Joint Diseases
Currently open trials in the same condition.
- NCT07391592 — Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate · active not recruiting
- NCT06404346 — Comparative Effectiveness of HVT and Bowen Technique in Patients of SI Joint Dysfunction With Upslipped Innominates · NA · active not recruiting
- NCT05844124 — Impact of Different Exercise Programs on Knee OA · NA · active not recruiting
- NCT04536103 — Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry · recruiting
- NCT04328181 — Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomo · NA · recruiting
Other MicroPort Orthopedics Inc. trials
Trials by the same sponsor.
- NCT07391592 — Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate · active not recruiting
- NCT04145401 — Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK · enrolling by invitation
- NCT03865667 — Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Preserve Femoral Stem · active not recruiting
- NCT03450733 — Wright Medical Technology Metal-on-Metal 522 Post-Market Surveillance Study · completed
- NCT02865447 — Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04147559 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MicroPort Orthopedics Inc.
- Last refreshed: 20 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04147559.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing